Utah Medical Products Inc
UTMD· Nasdaq
Released May 10, 2024, during market hours
10-Q filed May 10, 2024, 40 days after period end · 0001811884-24-000015
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $11.34M | $12.52M | $12.32M | $10.96M |
| Net Income | $3.96M | $4.21M | $3.53M | $3.02M |
| EPS Diluted | $1.09 |
Utah Medical Products Inc · CIK 706698 · Engraved from SEC EDGAR
| $1.16 |
| $0.96 |
| $0.83 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.